Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 780.0 | 49 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 996.0 | 65 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 1045.0 | 43 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 1106.5 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 1116.0 | 69 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | VEGF | 1060.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 1054.5 | 50 | |
N2645 | TNF-a | 100 | ng/mL | 4 | VEGF | 1180.0 | 58 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | VEGF | 1086.0 | 56 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | VEGF | 929.5 | 58 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | VEGF | 730.0 | 58 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | VEGF | 905.0 | 58 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | VEGF | 488.0 | 51 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | VEGF | 786.0 | 56 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | VEGF | 1074.0 | 43 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | VEGF | 1027.0 | 62 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | VEGF | 892.0 | 75 | ||||
RA2159 | 4 | VEGF | 964.0 | 51 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | VEGF | 661.0 | 35 | ||||
N2645 | 4 | VEGF | 855.5 | 62 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | VEGF | 1016.5 | 52 | ||||
RA2708 | 4 | VEGF | 791.0 | 45 | |||||||
RA2159 | 4 | VEGF | 793.5 | 58 | |||||||
N2645 | 4 | VEGF | 813.0 | 53 | |||||||
RA2708 | 4 | VEGF | 1194.0 | 60 |